NCT05157425 - Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

October 26, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

May 31, 2022

Conditions

Influenza Vaccine

Interventions

DIETARY_SUPPLEMENT

Food Supplement

Probiotic multistrain formulation containing Lactiplantibacillus plantarum CECT30292, CECT7484, CECT7485 and P. acidilactici CECT7483 for 28 days, starting the same day of influenza vaccination

DIETARY_SUPPLEMENT

Placebo

One maltodextrin-containing capsule/day for 28 days, starting the same day of influenza vaccination

Trial Locations (5)

18002

FIBAO- Fundación para la Investigación Biosanitaria de Andalucia Oriental, Granada

08401

Hospital General de Granollers, Granollers

08208

Hospital Parc Tauli, Sabadell

08930

IDIAP Jordi Gol-Centro de Atención Primaria La Mina, Sant Adrià de Besòs

08221

Mutua de Terrassa, Terrassa

All Listed Sponsors

lead

AB Biotics, SA

INDUSTRY